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ABSTRACT Transmissible spongiform encephalopathies in mammals are believed to be caused by scrapie form of prion
protein (PrPSc), an abnormal, oligomeric isoform of the monomeric cellular prion protein (PrPC). One of the proposed functions
of PrPC in vivo is a Cu(II) binding activity. Previous studies revealed that Cu2 binds to the unstructured N-terminal PrPC
segment (residues 23–120) through conserved histidine residues. Here we analyzed the Cu(II) binding properties of full-length
murine PrPC (mPrP), of its isolated C-terminal domain mPrP(121–231) and of the N-terminal fragment mPrP(58–91) in the
range of pH 3–8 with electron paramagnetic resonance spectroscopy. We find that the C-terminal domain, both in its isolated
form and in the context of the full-length protein, is capable of interacting with Cu2. Three Cu(II) coordination types are
observed for the C-terminal domain. The N-terminal segment mPrP(58–91) binds Cu2 only at pH values above 5.0, whereas
both mPrP(121–231) and mPrP(23–231) already show identical Cu(II) coordination in the pH range 3–5. As the Cu2-binding
N-terminal segment 58–91 is not required for prion propagation, our results open the possibility that Cu2 ions bound to the
C-terminal domain are involved in the replication of prions, and provide the basis for further analytical studies on the
specificity of Cu(II) binding by PrP.
INTRODUCTION
The cellular prion protein (PrPC) is a host-encoded cell
surface glycoprotein expressed mainly in the brain and to a
lesser extent in many other tissues (Prusiner, 1991; Prusiner,
1998). Prion-related diseases, known as transmissible spon-
giform encephalopathies, such as bovine spongiform en-
cephalopathy in cattle and Creutzfeldt-Jakob disease in hu-
mans, are fatal diseases supposed to be caused by a
conformational isomer of PrPC (PrPSc) (Prusiner, 1998;
Griffith 1967). PrPSc is an insoluble, proteinase K-resistant
oligomer of PrP that accumulates in the brain during infec-
tion with prions (Weissmann et al., 1996). The covalent
structure of the PrPSc subunits is supposed to be identical
with that of PrPC (Stahl and Prusiner, 1991). The mecha-
nism of the conversion of PrPC to its abnormal isoform
PrPSc is presently unknown, and it is still a matter of debate
whether the infectious scrapie agent is identical to PrPSc
(Griffith, 1967; Alper et al., 1967; Prusiner, 1982). Also the
function of PrPC remains unknown; several potential roles
of PrP have been postulated, including a possible interaction
with a ligand, which results in a signal essential for proper
neuronal function (Shmerling et al., 1998), a role in target-
ing the neuronal nitric oxide synthase to its normal subcel-
lular localization in cholesterol-rich membrane microdo-
mains (Keshet et al., 1999), and a role in copper
metabolism, related to the finding, that the prion protein can
bind copper ions (Brown et al., 1998; Pauly and Harris,
1998; Brown and Mohn, 1999; Wong et al., 1999; Herms et
al., 1999; Brown et al., 1999; Brown, 1999).
A first hint of a Cu2 binding ability of PrPC came from
the observation that hamster PrPC can be enriched by Cu2
chelate affinity chromatography (Pan et al., 1993). Subse-
quently, it was proposed that PrPC is also a Cu2 binding
protein in vivo, because the content of Cu2 in membrane
preparations of brains from prion protein deficient (PrP0/0,
Bu¨eler et al., 1992) mice was found to be only 20% of that
in wild-type mice (Brown et al., 1997a), although Wag-
goner et al. (2000) recently claimed that these data could not
be reproduced.
Nevertheless, binding of Cu2 to the prion protein has
been supposed to play a role in the pathogenesis of prion
diseases because PrP0/0 mice, albeit otherwise normal in
their phenotype (Bu¨eler et al., 1992), show a higher sensi-
tivity to copper toxicity and oxidative stress conditions
compared to the wild-type animals (Brown et al., 1996,
1997b). In addition, a decreased activity of the cuproen-
zyme superoxide dismutase (SOD) was found in brain ex-
tracts from PrP0/0 mice, and it was suggested that PrPC acts
as a Cu2 storage protein guaranteeing sufficient biological
activity of SOD (Brown et al., 1997b; Brown and Besinger,
1998). Several other findings support the idea of a correla-
tion between Cu2 binding to PrP and prion diseases. A
32-amino acid peptide representing residues 59–91 of the
human PrP, containing the four characteristic octapeptide
repeats of the N-terminal segment, has been shown to pro-
mote survival of PrP0/0 cerebellar cells in the presence of
Cu2 (Brown et al., 1998). In addition, Cu2 ions appar-
ently enhance recovery of proteinase K resistance after
treatment of PrPSc with guanidine hydrochloride, followed
by dilution to low guanidine hydrochloride concentrations
(McKenzie et al., 1998). Cu2 was also shown to stimulate
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endocytosis of the prion protein in cultured neuroblastoma
cells, suggesting that PrPC could serve as a receptor for the
uptake of copper ions in neuronal cells from the extracel-
lular milieu (Pauly and Harris, 1998). Furthermore, a pos-
sible localization of PrPC in the presynaptic membrane is
discussed, at which PrPC may modulate synaptic transmis-
sion by recapturing copper ions released into the synaptic
cleft (Herms et al., 1999). Very recently, Brown et al.
(1999) suggested that the recombinant mouse prion protein
itself has an activity like that of superoxide dismutase, but
only after refolding of PrP in the presence of excess copper
ions.
In contrast to the uncertainties about the function of PrPC
in vivo, a large body of structural information on PrPC has
become available from the NMR structure determination of
recombinant mouse (Riek et al., 1996), hamster (Donne et
al., 1997), and human (Zahn et al., 2000) PrPCs. The com-
mon structural feature of these mammalian PrPCs, which are
composed of 210 amino acids, is a well structured C-
terminal domain, extending from residues 125–228, and a
flexibly disordered N-terminal domain (residues 23–124).
The C-terminal domain consists of three -helices and a
two-stranded antiparallel -sheet; the only two cysteine
residues of the protein form a disulfide bridge connecting
helix 2 and 3.
Biophysical investigations on copper binding to PrPC
were so far mainly focused on peptides from the unstruc-
tured, N-terminal segment of PrP, which is characterized by
a highly conserved repeat of four octapeptide units with the
consensus sequence PHGGGWGQ. The histidine residue
contained in each repeat is the most obvious candidate for
Cu2 binding.
Regarding the stoichiometry of Cu2 binding to the N-
terminal segment of PrP, 2–6 copper ions have been pro-
posed to bind per PrPC molecule (Brown et al., 1997a;
Hornshaw et al., 1995a; Hornshaw et al., 1995b; Sto¨ckel et
al., 1998; Viles et al., 1999; Miura et al., 1999; Aronoff-
Spencer et al., 2000). These differences may be caused by
different pH-dependent protonation states of the histidine
residues and by buffer artifacts. The copper binding model
from Viles et al. (1999) proposes cooperative binding of
four copper(II) ions per PrP(58–91) peptide. In this model,
the coordination sphere is supposed to be practically iden-
tical for all of the four copper(II) bound, consisting of a
square-planar geometry with three nitrogen and one oxygen
ligand. Later, Whittal et al. (2000), working on fragments
from the unstructured, N-terminal domain of Syrian hamster
PrP (SHaPrP), found that the binding stoichiometry of Cu2
to PrPC is pH dependent, with two copper(II) bound at pH
6 to the octapeptide repeat region, and four copper(II) bound
at pH 7.4. The most recent copper binding model from
Aronoff-Spencer et al. (2000) confirmed binding of four
copper ions per PrP(57–91) peptide proposed by Viles et al.
(1999), with a detailed electron paramagnetic resonance and
circular dichroism analysis of copper(II) binding. Here, an
alternative mode of binding is suggested, in which the
coordinating water molecules proposed by Viles et al.
(1999) in the coordination sphere are replaced by backbone
carbonyl oxygens from glycine residues; furthermore, the
nitrogen ligands are provided by only one histidine residue
per Cu(II) ion and by two backbone nitrogens, in contrast to
the cooperative binding of Cu(II) by the nitrogens from two
histidine residues in neighboring repeat units and one back-
bone nitrogen as postulated by Viles et al (1999).
In this study, we examine the Cu2 binding to the re-
combinant full length mouse prion protein mPrP(23–231),
its structured C-terminal fragment mPrP(121–231), and the
N-terminal segment mPrP(58–91), containing the four con-
served octapeptide repeats, at different pH values with con-
tinuous wave electron paramagnetic resonance (CW EPR)
spectroscopy. This technique permits to selectively detect
protein-bound copper(II) ([Cu2]  20 M) and to obtain
information about the nature of its coordination sphere.
Copper(II) binding to the C-terminal structured part of
recombinant PrPC was observed. These unexpected results
are discussed in detail and compared to earlier observations.
Furthermore, the general problem of estimating the biolog-
ical relevance of Cu(II) binding studies performed at “high”
protein concentrations in vitro is discussed.
MATERIALS AND METHODS
Protein purification
Recombinant mPrP(23–231) and mPrP(121–231) were purified as de-
scribed (Liemann and Glockshuber, 1999). After purification, the proteins
were dialyzed against distilled water and stored at 20°C after freezing in
liquid nitrogen. Protein concentrations were determined by the specific
absorbance of the proteins according to Gill and von Hippel (1989) with
  19890 M1 cm1 for mPrP(121–231) and   62280 M1 cm1 for
mPrP(23–231).
The peptide mPrP(58–91), corresponding to the octapeptide repeat
containing region of mouse PrP, was purchased from Primm (Milan, Italy).
The peptide was synthesized by FMOC solid phase synthesis, and acety-
lated at the N terminus and amidated at the C terminus (sequence: GQPH-
GGGWGQPHGGSWGQPHGGSWGQPHGGGWGQ). The peptide was
purified by reversed phase HPLC and its molecular mass verified by matrix
assisted UV laser desorption/ionization time-of-flight mass spectrometry
(calculated mass: 3409.42 Da; found: 3408.09 Da). The peptide concen-
tration was determined by acquiring UV spectra of samples in 6 M
guanidine hydrochloride, using an extinction coefficient at 280 nm of
22760 M1 cm1.
Sample preparation
pH-dependent EPR measurements
The following buffers in the range of pH 3–8 were used (10 mM each):
formic acid/NaOH (pH 3.0 and 4.0), sodium acetate/HCl (pH 5.0), sodium
cacodylate/HCl (pH 6.0) and 3-(N-morpholino)propane-sulfonic acid/
NaOH (pH 7.0, 7.4 and 8.0). For the measurements of the Cu(II) binding
of mPrP(58–91), 2 or 4 molar equivalents CuCl2 were added to a stock
solution of the peptide to reach a final 0.1 mM peptide concentration at pH
3, 4, 5, 6 and 7.4. For the measurements of the Cu(II) binding of
mPrP(121–231) and mPrP(23–231) at pH 3.0 to 6.0, 3 molar equivalents of
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CuCl2 were added to 0.1 mM of the peptide in 10 mM buffer. Due to the
low solubility of Cu(II) at pH 7.0 to 8.0, the samples for measurements at
these pH values were prepared by dialysis of the metal-free protein against
the same buffer without CuCl2 to remove free Cu2. Because mPrP(121–
231) shows a strong aggregation tendency upon addition of Cu2 at pH
7–8, the concentration of soluble protein after dialysis was too low to give
interpretable EPR spectra. However, by addition of 0.8 molar equivalents
of CuCl2 to 0.1 mM PrP(121–231) at pH 7.4, an EPR spectrum with good
signal-to-noise ratio was obtained. Buffer solutions with free Cu2 (0.3
mM CuCl2) were prepared as control.
Titration experiments at pH 4.0 and 6.0
A stock solution of mPrP(23–231) or mPrP(121–231) (70 l, 0.143 mM in
H2O) was mixed with 20 l of 50 mM sodium cacodylate/HCl (pH 6.0), or
50 mM formic acid/NaOH (pH 4.0) and 10 l of a CuCl2 solution (0.25–20
mM in H2O) (final protein concentration, 0.1 mM; final Cu2 concentra-
tion, 0.025–2 mM).
Samples of refolded PrP
mPrP(23–231) or mPrP(121–231) (0.8 mM each) in 25 mM sodium
acetate/HCl, pH 4.0 (same conditions as in Negro et al., 1997), 8 M urea,
was allowed to refold for 1 h at 15°C after a 1:30 dilution with 25 mM
sodium acetate/HCl (pH 4.0). The refolded protein was extensively dia-
lyzed against distilled water at 4°C. The final protein solution had a pH of
5.6. For EPR measurements, the protein solutions were again concentrated
to 0.1 mM. In another set of experiments, refolding was performed under
the same conditions, but in the presence of 1 mM CuCl2, followed by
dialysis against distilled water as described above. A final glycerol content
of 10% (v/v) was used for the EPR measurements.
Samples for circular dichroism measurements
A stock solution of PrP(23–231) was used to prepare samples of 10 M
PrP(23–231) with or without 0.1 mM CuCl2 in distilled water without
buffer or with 10 mM formic acid/NaOH, pH 4.0. The sample of PrP(23–
231) refolded in the presence of 1 mM CuCl2 and dialyzed against distilled
water was prepared as described in the previous paragraph.
Continuous wave EPR spectroscopy
The EPR spectra were recorded on a Bruker ESP300 spectrometer (micro-
wave frequency 9.43 GHz), equipped with a ER4131 VT digital temper-
ature control system, making use of gaseous nitrogen as a coolant. A
microwave power of 20 mW, a modulation amplitude of 0.5 mT, and a
modulation frequency of 100 kHz were used. All spectra were recorded at
a temperature of 120 K. The EPR spectra were simulated using the
EasySpin program, a MATLAB toolbox developed for EPR simulations
(http://www.esr.ethz.ch).
In order to evaluate the titration results, the double integrals of the EPR
spectra were calculated after second order base-line correction. All values
were normalized to the same amount of protein.
Circular dichroism spectra
Far-UV circular dichroism (CD) spectra were measured at 25° C on a Jasco
710 CD spectropolarimeter in 0.1-cm quartz cuvettes, accumulated 8 times
and corrected for the corresponding buffer. Protein samples were centri-
fuged (5 min, 14,000 rpm, 25° C) before the concentration and CD
measurements in order to remove possible aggregates.
RESULTS
The EPR spectra of the full-length murine prion protein,
mPrP(23–231) in the presence of Cu2 (Figs. 1, 3) are
typical for type-2 protein-copper(II) complexes (axial g
matrix, copper hyperfine coupling, A  400 MHz) (Mess-
erschmidt, 1998; Kaim and Rall, 1996). Type-2 complexes
are largely square-planar with a possible fifth weak coordi-
nation. Naturally occuring type-2 copper proteins do not
contain sulfur ligands, although type-2 copper sites with
cysteinate ligation have been generated using genetic engi-
neering (Messerschmidt, 1998). For type-2 copper com-
plexes, the (g, A) values correlate with the type of the
equatorially coordinating atoms (Peisach and Blumberg,
1974). Unfortunately, the g and A values depend also on
the charge of the surrounding ligands and a possible fifth
ligand, so that a clear-cut determination of the coordination
sphere on the basis of the EPR data alone is not possible.
Nevertheless, the g and A values can be used to get a first
hint about the coordinating atoms.
FIGURE 1 X-band EPR. spectra of 0.1 mM mPrP(23–231) with 3 molar
equivalents, CuCl2 at pH 3 (A), 4 (B), 5 (C), and 6 (D), and of 0.1 mM
mPrP(121–231) with 3 molar equivalents, CuCl2 at pH 3 (E), 4 (F), 5 (G),
and 6 (H).
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The pH dependence of the copper(II)-PrP
interaction
Fig. 1 (A–D) shows the EPR spectra of 100 M mPrP(23–
231) in the presence of 3 molar equivalents of CuCl2 at pH
3.0–6.0. Buffer solutions with 0.3 mM CuCl2 were also
examined to confirm that the observed EPR spectra were
due to copper binding to the protein. The EPR spectra of
copper(II) with two different coordination spheres (1 and 2
in Fig. 1) are observed; the ratio of both binding modes
depends on pH. The g and A values of complex 1 (Table
1) are in agreement with three types of copper ligation,
namely ligation to two nitrogens and two oxygens (2N2O),
to one nitrogen and three oxygens (1N3O), or to four
oxygens (4O). For complex 2, the EPR parameters (Table 1)
are in agreement with the four combinations 3N1O, 2N2O,
1N3O, or 1N2O1S (Peisach and Blumberg, 1974; den Blau-
wen and Canter, 1993).
Fig. 1 (E—H) shows the corresponding EPR spectra of
the isolated C-terminal domain of murine PrP, mPrP(121–
231), with 3 molar equivalents of CuCl2 in the same pH
range. The same complexes 1 and 2 are found as in the case
of mPrP(23–231) (Fig. 1 A—D).
Fig. 2 B, D, and F show the X-band EPR spectra of
mPrP(58–91) with four equivalents of Cu2 at pH 4, 5, and
6. Fig. 2, A, C, E depict the corresponding buffer controls
with 0.3 mM Cu2. The spectra reveal that mPrP(58–91)
does not bind Cu(II) below pH 6 in contrast to mPrP(121–
231) and mPrP(23–231) (Fig. 1). At pH 6, the EPR spec-
trum of mPrP(58–91) with Cu2 (Fig. 2 F) consists of two
components, the Cu(II)-buffer signal (Fig. 2 E) and the
Cu(II)-bound mPrP(58–91) signal (complex 4, Table 1).
The EPR parameters of complex 4 are different from those
observed for complex 1 and 2. This indicates that, up to pH
6, Cu2 preferably binds to the C-terminal segment of the
mouse prion protein and not, as expected (Hornshaw et al.,
1995a,b; Sto¨ckel et al., 1998; Viles et al., 1999; Miura et al.,
1999; Whittal et al., 2000), to the histidine-rich N-terminal
region.
At pH 7.0–8.0, Cu2 salts have a low solubility. To
analyze Cu2 binding to PrP at pH 7–8, metal-free
mPrP(23–231) and mPrP(121–231) were dialyzed at con-
centrations of 0.1 mM against a buffer solution containing
50 M CuCl2. Thereafter the protein solutions were dia-
lyzed against the same buffers without copper to remove
unbound Cu2. The corresponding EPR spectra are shown
in Fig. 3 (A–C). The EPR spectra of mPrP(23–231) at pH
7.0–8.0 lack the features of complex 1, but exhibit an
additional contribution corresponding to a new coordination
sphere (complex 3, table 1). Complex 2 is still observed.
The g and A values of complex 3 are in agreement with the
ligations 4N, 3N1O, 2N2O, or 2N1O1S (Peisach and Blum-
berg, 1974; den Blauwen and Canter, 1993; van Pouderoyen
et al., 1996).
Because mPrP(121–231) shows a strong aggregation ten-
dency upon addition of CuCl2 at pH 7.0–8.0, the effective
concentration of the remaining soluble protein in solution
after dialysis was too low to give interpretable EPR spectra.
However, by addition of less than 1 molar equivalent Cu2
to mPrP(121–231) at pH 7.4, a spectrum with sufficient
signal-to-noise ratio was obtained (Fig. 3 D). Complex 2
and complex 3 contributing to this EPR spectrum are the
same as those found for mPrP(23–231) at pH 7.4. The EPR
spectrum of Cu(II)-bound mPrP(58–91) (Fig. 2 G) consists
of a complex 3-type coordination and complex 4. The
finding that a complex 3-type coordination sphere is also
formed for mPrP(58–91) at pH 7.4 will be treated in the
Discussion section.
Titration of mPrP(23–231) and mPrP(121–231) with
increasing amounts of Cu2
To investigate further the finding that copper(II) binds to the
C-terminal part of the prion protein at pH  7, different
molar equivalents of CuCl2 were added to mPrP(23–231)
and mPrP(121–231) at pH 4.0 and pH 6.0. The pH-value in
the lysosomes, where the scrapie isoform of the prion pro-
tein accumulates, is 4.0–6.0 (Lee et al., 1996), hence the
choice of the pH values for the titration.
Fig. 4 A shows the control EPR spectrum of the formic
acid/NaOH buffer solution (pH 4.0) with 0.3 mM CuCl2.
TABLE 1 EPR parameters of the type-2 Cu(II) complexes observed in copper containing full-length mPrP(23–231).
Complex g (0.005), g (0.005) A (10) (MHz) A (10) (MHz) Observed in pH
1 2.068 2.332 12 452 mPrP(121–231) 3–6
mPrP(23–231)
2 2.068 2.295 20 457 mPrP(121–231) 3–8
mPrP(23–231)
3 2.055 2.230 50 495 mPrP(121–231) 7–8
mPrP(58–91)
mPrP(23–231)
4 2.055 2.270 50 520 mPrP(58–91) 6, 7.4
5 2.114 Not resolved mPrP(23–120) 4  6
 4 equivalents Cu2
The hyperfine data are given for 63Cu. The location of the Cu(II) complexes in the protein and the pH values at which they are observable are also given.
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Upon addition of 0.25 to 4 molar equivalents of CuCl2 to
a 0.1 mM mPrP(121–231) solution at pH 4, the EPR
spectra show a mixture of contributions from complexes
1 and 2 (Fig. 4, B and C). There seems to be no special
preference for one of these complexes, because the EPR
spectra of both complexes are already visible when 1
molar equivalent of Cu2 is added. The EPR signal
intensities increase linearly with the number of molar
equivalents CuCl2 added to the solution. From 5 molar
equivalents of Cu2 onwards, three copper(II) complexes
contribute to the EPR spectrum of mPrP(121–231) at pH
4 (Fig. 4 D). The additional EPR spectrum is due to the
copper(II)-formate complex (Fig. 4 A). This contribution
increases with increasing concentration of CuCl2, indi-
cating that mPrP(121–231) binds a maximum of four
copper(II) ions at pH 4.
When up to 4 molar equivalents of CuCl2 were added to
a 0.1 mM solution of full-length mPrP(23–231) at pH 4, the
same behavior as for mPrP(121–231) was observed (Fig. 4,
E and F). Upon addition of 5 to 10 molar equivalents of
Cu2 to mPrP(23–231), however, the overall EPR spectrum
changed in the g-region, but no feature was found that
corresponds to the copper(II)-formate complex (Fig. 4, G
and H). Only from 12 molar equivalents of CuCl2 onwards,
a contribution of non-protein-bound Cu2 in the form of the
copper(II)-formate complex became visible (Fig. 4 I).
Moreover, from 4 to 10 molar equivalents of CuCl2, the
signal intensity did not change in the 260 to 280 mT region.
Fig. 5 shows the difference between the EPR spectra of
mPrP(23–231) with 10 and 4 molar equivalents of CuCl2.
The resulting EPR signal does not show resolved hyperfine
splittings (Table 1, complex 5), indicating that the Cu(II)
complexes are in close vicinity to each other. Large local
FIGURE 2 X-band EPR spectra of the peptide mPrP(58–91) between
pH 3 and 7.4 in the presence of Cu2. Spectra of buffer at pH 4 with 0.3
mM CuCl2 (A), mPrP(58–91) with 4 molar equivalents of Cu2 at pH 4
(B), buffer at pH 5 with 0.3 mM CuCl2 (C), mPrP(58–91) with 4 molar
equivalents of Cu2 at pH 5 (D), buffer at pH 6 with 0.3 mM CuCl2 (E),
mPrP(58–91) with 4 molar equivalents of Cu2 at pH 6 (F), mPrP(58–91)
with 2 molar equivalents of Cu2 at pH 7.4 (G) are shown.
FIGURE 3 X-band EPR spectra of mPrP(23–231) dialyzed against a
buffer solution at pH 7.0 (A), 7.4 (B), and 8.0 (C) with 50 . M. CuCl2,
with subsequent dialysis against the same buffers lacking Cu2. As a
comparison, the EPR spectrum of mPrP(121–231) with less than one molar
equivalent copper added at pH 7.4 is also shown (D).
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concentrations of Cu(II) complexes are shown to cause
inevitable broadening of the EPR lines (Bru¨ggeller and
Mayer, 1980).
Analogous results were obtained at pH 6.0. In the pres-
ence of 0–3 molar equivalents of CuCl2 relative to
mPrP(121–231), the EPR intensity increased linearly with
Cu2 concentration, but the C-terminal domain aggregated
upon addition of 4 molar equivalents of Cu2. On the
contrary, the full-length prion protein did not aggregate,
even in the presence of 20 equivalents of Cu2. In the range
of 0–4 equivalents of CuCl2, the typical EPR spectrum
shown in Fig. 1 (pH 6) was observed. For 5 or more molar
equivalents of Cu2, the spectrum altered, although the
changes were not as clearly interpretable as in the pH 4 case.
At concentrations corresponding to 12 equivalents of
Cu2, the Cu2-buffer EPR spectrum became visible, indi-
cating that also at pH 6, the prion protein can bind up to 12
equivalents of Cu2.
Pulse EPR and electron-nuclear double
resonance results
In order to analyze the above findings further, pulse EPR
and electron-nuclear double resonance (ENDOR) measure-
ments were undertaken (Van Doorslaer et al., 2001). Here
we mention those results which are of importance for the
present investigation. All pulse EPR and ENDOR spectra of
Cu(II)-bound mPrP(121–231) and of Cu(II)-bound
mPrP(23–231) at pH 5.6 were identical, confirming again
that the observed Cu(II) binding takes place in the C-
terminal part of the protein. For complex 2, the hyperfine
sublevel correlation spectroscopy and Davies-ENDOR
spectra revealed the interactions with the remote and di-
rectly coupled nitrogen of one histidine ligand. For complex
1, no interactions with directly coordinating nitrogens were
observed. Finally, the Davies-ENDOR analysis of
mPrP(23–231) at pH 7.4 showed that more than one nitro-
gen atom is directly bound to copper in complex 3.
Influence of Cu2 on the refolding of oxidized
mPrP(23–231)
To analyze the influence of Cu2 on the conformation of
mPrP(23–231) after refolding from the urea-denatured state,
unfolded mPrP(23–231) (pH 4, 8 M urea) was allowed to
refold in the presence of a 10-fold molar excess of CuCl2 for
1 h and was then extensively dialyzed against distilled water
at 4°C to remove unbound copper ions. The final pH was
5.6. The resulting CW EPR spectrum of the concentrated
sample (0.1 mM) is shown in Fig. 6 A. In a parallel exper-
iment, CuCl2 was added to a solution of native mPrP(23–
231) at pH 4 in the absence of urea, and the sample was then
dialyzed extensively against distilled water as described
above. The resulting EPR spectrum at pH 5.6 is identical
(Fig. 6 B) and proves that Cu2 binds to mPrP(23–231)
independent of whether Cu2 is added before or after re-
FIGURE 5 Difference EPR spectrum of mPrP(23–231) in the presence
of 10 molar equivalents CuCl2, and mPrP(23–231) in the presence of 4
molar equivalents CuCl2 at pH 4 (cf. Fig. 3).
FIGURE 4 Titration experiments at pH 4.0. X-band EPR spectra of the
following samples are shown: buffer control (formic acid/NaOH buffer
(pH 4.0) and 0.3 mM CuCl2) (A), mPrP(121–231) with 0.75 (B), 4 (C), and
5 (D) molar equivalents CuCl2 (pH 4) and mPrP(23–231) with 0.5 (E), 4
(F), 5 (G), 10 (H), and 12 (I) molar equivalents CuCl2 (pH 4). For clarity,
the low-field part of the spectra, D and I, are shown in triple magnification.
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folding. The same result was found for mPrP(121–231)
(data not shown).
In addition, the CD spectra of mPrP(23–231) in water and
25 mM sodium acetate/HCl (pH 4.0) are identical to those
of mPrP(23–231) in the presence of 10 molar equivalents of
CuCl2, as well as to that of mPrP(23–231) refolded in
presence of Cu2 and dialyzed against distilled water. This
indicates that there is no substantial change in protein con-
formation due to refolding in the presence of Cu2 (Fig. 7).
DISCUSSION
One has to be cautious in evaluating and comparing differ-
ent studies of in vitro Cu(II) binding to prion proteins. First
of all, the used analytical methods are usually sensitive in
different concentration ranges. On the one hand, techniques
suitable for structure analysis, such as NMR, Raman or EPR
spectroscopy, are only sensitive at “high” protein and/or
Cu2 concentrations (25 M–20 mM) (Viles et al., 1999;
Miura et al., 1999; Aronoff-Spencer et al., 2000). On the
other hand, analytical techniques such as CD, fluorescence
and electron spray ionization mass spectrometry (ESI-MS)
spectroscopy are sensitive to peptide and Cu2 concentra-
tions in the 1–10 M region, but cannot give detailed
structural information on the binding sites (Hornshaw et al.,
1995a,b; Sto¨ckel et al., 1998; Viles et al., 1999; Whittal et
al., 2000). One of the missing links is a test to which extent
the observed Cu(II) binding avidity of PrP is dependent on
protein concentration. In this work, we tested the stability of
the observed Cu(II) complexes by dialyzing the solutions of
mPrP(23–231) and mPrP(121–231) with Cu2 at pH 4
against water. During dialysis the protein concentration was
lowered to 3.3 M. Under these conditions, weakly and
nonspecifically bound Cu(II) ions are expected to be re-
moved. After dialysis, the protein was again concentrated to
a final concentration of 100 M. The fact that the same
Cu(II) complexes were observed for these samples as for
those in which Cu2 was directly added to the protein
solution provides strong evidence for specific binding.
Second, several in vitro studies on Cu(II)-binding to the
prion protein were done with small synthetic peptide seg-
ments of the protein (Hornshaw et al., 1995a,b; Miura et al.,
1999; Viles et al., 1999; Whittal et al., 2000; Aronoff-
Spencer et al., 2000) and the question remains whether the
behavior of these peptides is representative for the full-
length protein. In this work, we therefore compared the
results of the protein segments mPrP(121–231) and
mPrP(58–91) with those of the full-length protein.
Finally, the biological interpretation of the different an-
alytical results is rendered difficult by the fact that PrP is a
membrane protein. As PrPC is not an integral membrane
protein, but attached to the cell surface via a GPI anchor, it
is supposed to have a high lateral mobility within the
membrane. Therefore, the effective concentration of the
protein on the surface of the living cell is certainly high, not
only in general terms due to its exclusive localization in a
two-dimensional membrane, but also in terms of relative
PrPC concentrations. Moreover, the prion protein might
interact with another protein at the membrane that stabilizes
PrPC-Cu(II) complexes. Futhermore, although the copper
concentration is relatively high in the brain compared to
other tissues (23 g/g dry weight), the total copper content
of different brain regions varies widely. The highest values
are found in the locus ceruleus (1.4 mM), whereas the
concentration of free copper ions in the cerebrospinal fluid
FIGURE 6 X-band EPR spectra of Cu(II)-bound mPrP(23–231). (A)
mPrP(23–231) after refolding in the presence of CuCl2 and subsequent
dialysis to a final pH 5.6. (B) mPrP(23–231) after addition of CuCl2 and
subsequent dialysis to a final pH 5.6. Both samples contained 10% (v/v)
glycerol.
FIGURE 7 Circular dichroism (CD) spectra of 10 M mPrP(23–231) in
absence or presence of 10 molar equivalents CuCl2. Ten-M mPrP(23–
231) in water without (E) or with Cu2 (F), in 25 mM sodium acetate, pH
4.0, without () or with Cu2 (f), and refolded in the presence of 10
molar equivalents Cu2 at pH 4.0 and thereafter extensively dialyzed
against water (Œ). The symbols depict 7–11 data points from each mea-
surement.
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is only 0.24–0.28 M (Geigy Scientific Tables, 1981). In
view of all these factors it is principally difficult to correlate
different in vitro results with Cu(II) binding of the prion
protein in vivo.
In this work, different pH-dependent modes of copper
complexation were observed in vitro for mPrP(23–231).
Because the EPR spectra of complex 1 and 2 are observed
in Cu(II)-bound mPrP(23–231) and mPrP(121–231), but not
in Cu(II)-bound mPrP(58–91), they can be ascribed to
Cu(II) binding sites in the structured C-terminal part of the
protein.
Complex 1 is mainly observed at pH values  7.0. Its
EPR parameters suggest strong oxygen ligation (4O, 3O1N,
or 2O2N). The fact that complex 1 forms the major fraction
at pH 3.0 suggests that, for this complex, glutamic or
aspartic acid are involved in the ligation of Cu(II). This
agrees with the lack of nitrogen interactions in Davies-
ENDOR or hyperfine sublevel correlation spectroscopy ex-
periments (Van Doorslaer et al., 2001).
Complex 2 is visible throughout the investigated pH
range of 3–8, although the contribution of this complex to
the CW EPR spectrum decreases strongly below pH 5.0.
The EPR parameters indicate that at least one nitrogen atom
binds to the Cu2 ion. The pH dependence of this complex
suggests ligation of a histidine residue, which was con-
firmed by the pulse EPR and ENDOR studies (Van
Doorslaer et al., 2001). mPrP(121–231) contains three his-
tidines, H140, H177, and H187, that are too far apart in the
structure to allow concerted Cu2 binding. The possible
involvement of the N-terminal amino group of mPrP(23–
231) in the metal ligation, as observed for octapeptide repeat
peptides (Whittal et al., 2000), can be ruled out for com-
plexes 1 and 2 based on the pulse EPR/ENDOR results (Van
Doorslaer et al., 2001) and on the fact that both complexes
are observed at low pH.
The observation that mPrP(58–91) does not bind Cu2 at
pH values below 6 is in agreement with the studies of Cu(II)
binding to the octarepeat peptides of the N-terminal part of
the mature Syrian hamster prion protein SHaPrP (Viles et
al., 1999) and of the human PrP (Aronoff-Spencer et al.,
2000). At pH 6, mPrP(58–91) binds Cu(II) (complex 4,
table 1). The EPR parameters of complex 4 are clearly
different from those of complexes 1 and 2, but bear strong
resemblance with those observed for Cu(II)-bound PrP(23–
28, 57–91) at pH 6.75 (g 2.27 0.01, g 2.06 0.01,
A  536  6 MHz) (Aronoff-Spencer et al., 2000). Com-
plex 4 is still visible at pH 7.4 (Fig. 2 G), in accordance with
the observations of Aronoff-Spencer et al (2000).
The EPR parameters of complex 3 indicate a large in-
volvement of nitrogen atoms in the Cu2 ligation (2O2N,
1O3N, 4N, or 2N1S1O). Analogous data were found for
Cu(II)-bound PrP(23–28, 57–91) at pH 7.45 (g  2.23 
0.01, g  2.06  0.01, A  493  6 MHz) (Aronoff-
Spencer et al., 2000). Davies-ENDOR measurements of
Cu(II)-bound mPrP(23–231) at pH 7.4 confirmed that the
Cu(II) ion is directly coupled to more than one nitrogen
atom (Van Doorslaer et al., 2001). Complex 3 is only visible
at pH  7, suggesting that backbone nitrogens can be
involved, because 1:2 Cu-peptide complexes in alkaline
solutions, in which Cu(II) directly binds to backbone nitro-
gens, have similar g and copper hyperfine values (Szabo´-
Pla´nka et al., 1989). The fact that complex 3 is found in the
EPR spectra of all three Cu(II)-bound peptides indicates that
at pH  7 both mPrP(121–231) and mPrP(51–85) have
very similar Cu(II) binding sites giving rise to quasi the
same EPR spectrum. Further investigations will be neces-
sary to elucidate the exact nature of the coordination
spheres.
Whittal et al. (2000) reported that only weak and appar-
ently nonspecific binding of Cu2 could be found for SHa-
PrP(90–144) and mPrP(177–230) using ESI-MS. Protein
concentrations of 10 M and pH values 6 and 7.4 were used
in this study, which makes a direct comparison with our data
difficult. However, the ESI-MS findings do not necessarily
imply that the Cu(II) complexes observed with EPR are
nonspecific, as the isolated structured domain mPrP(121–
231) was not investigated by Whittal et al. Furthermore, our
dialysis tests support the model of specific binding of Cu2
to the structured part of the protein.
Complex 5 is exclusively observed with full-length PrPC
upon addition of 4 molar equivalents of Cu2. The ob-
servation that full-length PrPC may bind 10–11 Cu2 ions at
pH 4, whereas the N-terminal mPrP(58–91) does not bind
Cu2 and mPrP(121–231) binds only 4 equivalents of Cu2
seems to indicate that most of the binding sites contributing
to signal 5 are non-specific. This is corroborated by the fact
that complex 5 is not found after dialysis of the sample. At
pH 6, mPrP(58–91) binds specifically Cu2 (4). However,
the large uptake of Cu2 found for mPrP(23–231) at this pH
and the observed broadening of the EPR signals when more
than 4 equivalents of Cu2 are added suggest that besides
the specific binding also non-specific binding is taking
place. This agrees with the earlier observation that the
octarepeats nonspecifically bind Cu(II) at high Cu/peptide
ratios (Whittal et al., 2000).
Due to the observed cooperative binding of Cu2 ions
to the four histidines contained in the octapeptide repeats
of the unstructured, N-terminal region 60–91 of PrPC it
was so far assumed that the copper binding properties of
the prion protein are mainly attributable to this region of
the protein (Hornshaw et al., 1995a,b; Sto¨ckel et al.,
1998; Viles et al., 1999; Miura et al., 1999; Whittal et al.,
2000; Aronoff-Spencer et al., 2000). Our result that the
C-terminal part of the prion protein binds Cu(II) raises
the possibility of Cu2 binding to the recently described
prion analog (prion doppel), which has been proposed to
share structural similarities with the C-terminal domain
of PrPC, but lacks the N-terminal octapeptide repeats
(Moore et al., 1999; Weissmann and Aguzzi, 1999). In
addition, because the structured C-terminal domain of
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mouse PrPC can bind Cu2, this Cu2 binding ability
must consequently be attributed also to the fragment of
the prion protein ranging from residue 90 to residue 231.
Because this fragment is still capable of propagating
prion disease (Shmerling et al., 1998), our results open
the possibility that Cu(II)-bound PrPC may be involved in
the transition to PrPSc. Furthermore, our present finding
that the full-length prion protein can bind Cu(II) at pH
values 6 is interesting in view of the fact that the
scrapie isoform of the prion protein accumulates in the
lysosomes (pH 4–6) (Lee et al., 1996). Finally, the
observed affinity of mPrP(23–231) for Cu2 principally
supports the hypothesis of a copper receptor or storage
function of the prion protein in neuronal cells (Pauly and
Harris, 1998; Herms et al., 1999), although we have to
consider contributions of nonspecific binding.
In this study, we also analyzed the influence of Cu2
on the refolding of urea-denatured, disulfide-intact
mPrP(23–231) and mPrP(121–231). Brown et al. (1999)
reported that only acquisition of Cu2 by PrPC during
protein folding endowed SOD activity on the protein, but
the addition of copper after refolding did not. Our present
study shows, however, that binding of Cu2 to the full-
length mouse prion protein is independent of whether the
protein was allowed to refold in the presence of Cu2, or
Cu2 was added after refolding. The discrepancy be-
tween our results and those of Brown et al. (1999) may
result from different protein preparations. Specifically,
the disulfide bond in all proteins used in the present study
was quantitatively formed (Liemann and Glockshuber,
1999). Brown and co-workers did not first oxidize the
two cysteine thiols of PrP before the copper-addition
experiments. Thus, if the buried disulfide bond is not
formed, the free cysteines may interact with the Cu2
ions, leading to a non-native protein conformation and a
non-native copper coordination sphere.
In conclusion, analysis of Cu2 binding to the recom-
binant mouse prion protein with EPR shows that Cu2
ions can bind to the structured C-terminal part of the
protein. Cu2 ions bound to this domain show three
different coordination geometries, one of which involves
the nitrogen atom of one of the three histidines contained
in mPrP(121–231). This finding opens again the discus-
sion on the possibility that Cu2 is involved in the
process of PrPSc formation and a putative function of
PrPC in the Cu2 metabolism. Furthermore, our observa-
tions provide the basis for further investigations of the
Cu(II) binding avidity and specificity of the C-terminal
domain of the prion protein with different analytical
techniques.
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